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Alterations in Oxidative Stress Status 
During Early Alcohol Withdrawal in
Alcoholic Patients
Ming-Chyi Huang,1,2 Chun-Hsin Chen,2,3 Fu-Chuo Peng,4 Sheng-Hui Tang,5 Chiao-Chicy Chen1,2*
Background/Purpose: Alcohol-induced oxidative stress is the result of the combined production of reactive
oxygen species [ROS; e.g. malondialdehyde (MDA), an index of lipid peroxidation] and impairment of
antioxidant defenses [e.g. superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX),
which are involved in the elimination of ROS]. Little is known about the oxidative stress markers among
patients with alcohol dependence in Taiwan. This study aimed to investigate serial alterations of various
oxidative stress markers during early detoxification in alcoholic patients.
Methods: We enrolled 121 inpatients who fulfilled the DSM-IV-TR criteria for alcohol dependence, and 
19 healthy controls. Fasting serum MDA level and antioxidant activity, including SOD, CAT and GPX, were
measured at baseline in both groups, and after 1 and 2 weeks of detoxification in alcoholic patients.
Results: MDA level in alcoholics was higher at baseline than in healthy controls. It decreased after 1 week
of detoxification, and normalized at week 2. SOD and GPX activities remained significantly lower through-
out the 2-week period. CAT activity in alcoholics was comparable to that in the controls at baseline, but
decreased at week 1 of detoxification, and was significantly lower than that in the controls after 2 weeks.
Moreover, baseline MDA level was correlated with baseline CAT activity in alcoholics; the magnitude of the
decrease in MDA level was correlated with the decrease in CAT activity following the 1-week detoxification.
Conclusion: The findings suggest severe oxidative stress and weakened antioxidant activity in alcoholic
patients, and limited changes in oxidative stress in the early stages of alcohol withdrawal. [J Formos Med
Assoc 2009;108(7):560–569]
Key Words: alcoholism, alcohol detoxification, alcohol withdrawal, malondialdehyde, oxidative stress
Excessive alcohol consumption has been reported
as one of the leading causes of mortality.1,2
Alcohol affects organ systems as a result of gener-
ation of free radicals during the metabolism of
ethanol. Alcohol must be metabolized, primarily
in the liver, through alcohol dehydrogenase and
acetaldehyde dehydrogenase. The other path-
way for alcohol metabolism is ethanol-inducible 
cytochrome P450 2E1 (CYP2E1). This is nor-
mally a minor pathway, but may play an impor-
tant role at high ethanol levels and in chronic
alcoholics.3,4
CYP2E1-mediated metabolism induced by 
alcohol generates more toxic metabolites than the
parent compounds, including reactive oxygen
species (ROS; superoxide anion and hydrogen 
©2009 Elsevier & Formosan Medical Association
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, 2Department of Psychiatry, School of
Medicine, Taipei Medical University, 3Department of Psychiatry, Taipei Medical University-Wan-Fang Hospital, 4Institute
of Toxicology, College of Medicine, National Taiwan University, and 5Toxic Center, Tri-Service General Hospital, Taipei,
Taiwan.
Received: May 27, 2008
Revised: July 20, 2008
Accepted: December 30, 2008
*Correspondence to: Professor Chiao-Chicy Chen, Department of Psychiatry, Taipei
City Psychiatric Center, Taipei City Hospital, 309 Song-De Road, Xing-Yi District,
Taipei 100, Taiwan.
E-mail: cchen@tpech.gov.tw
peroxide) as well as ethanol-derived (hydroxyethyl)
free radicals.5,6 These products cause DNA dam-
age, generate protein adducts, and initiate lipid
peroxidation. Lipid peroxidation reflects the inter-
action between oxygen molecules and polyunsat-
urated fatty acids, and induces oxidation of various
breakdown products of the latter. Among these,
malondialdehyde (MDA) is a reliable marker of
oxidative damage.6–8 However, to protect the body
from the adverse effects of free radicals, there 
are several antioxidant defense mechanisms that
are involved in the elimination of ROS, includ-
ing superoxide dismutase (SOD), catalase (CAT),
and glutathione peroxidase (GPX). SOD catalyzes
superoxide radicals to hydrogen peroxide and
thus is critical for prevention of damage from
further toxic oxidative radicals generated by alco-
hol consumption.9 CAT and GPX are responsible
for further metabolism of hydrogen peroxide to
water and oxygen.
Many studies have investigated the effect of
alcohol on oxidative stress in humans. In com-
parison to controls, in alcoholics, MDA levels in-
creased significantly in cerebrospinal fluid (CSF)
or peripheral blood.10,11 Reductions in lipid per-
oxidation have been reported consistently follow-
ing alcohol withdrawal, despite various markers
being utilized in different studies.12–14 In gen-
eral, antioxidant activity is lower in chronic alco-
holics than in control subjects. Several studies
have found that SOD and GPX activities are 
reduced after 2–3 weeks of alcohol withdrawal
compared with those at baseline,12,15,16 while
one study has demonstrated that the deficiency
in SOD activity did not improve from day 9 to
33.10 Erythrocyte CAT activity shows no difference
between alcoholics and controls, or after absti-
nence for alcoholics.16,17
Glutamate over-excitation has long been impli-
cated in the pathophysiology of alcohol withdrawal
symptoms.18–20 Oxidative stress and excessive ac-
tivation of glutamate receptors represent sequen-
tial as well as interacting processes. Since alcohol
withdrawal symptoms mostly subside after 1–2
weeks of detoxification, it is important to explore
the oxidative status during early withdrawal.
Therefore, the aim of the present study was to ex-
plore the serial alterations of various oxidative
parameters simultaneously throughout 2 weeks
of alcohol detoxification in alcoholic patients in
Taiwan, and to confirm the previous conflicting
results by using a very small sample size.21 We
also examined the correlation between oxidative
markers with regard to baseline values or the 
extent of changes.
Subjects and Methods
Subjects
This study was approved by the Institutional
Review Board of Taipei City Psychiatric Center
(TCPC). Alcoholic patients who were scheduled
to be admitted to the alcohol detoxification ward
in TCPC received a routine complete medical 
examination. Those with known severe physical
illnesses were referred instead to a medical ward
(e.g. patients with severe liver cirrhosis, infection,
or those with post-admission illness). Between
August 2003 and July 2005, patients were sub-
jected to a thorough interview by two psychia-
trists to ascertain the fulfillment of DSM-IV-TR
(Diagnostic and Statistical Manual of Mental Dis-
orders, 4th edition, text revision) criteria for alco-
hol dependence. Eligible patients were not using
illicit drugs, did not have chronic systemic dis-
eases such as diabetes mellitus or complicated
cardiovascular disease, did not show any clinical
evidence of the above-mentioned illnesses, or 
severe mental disorders, such as schizophrenia,
bipolar disorder, or major depressive disorder. The
control group included healthy subjects without
known physical or psychiatric illnesses, identi-
fied by interview, as well as the results of routine
laboratory tests. They had not previously met the
diagnostic criteria for alcohol abuse or depen-
dence, nor had they consumed alcohol during
the previous 3 months. Written informed con-
sent was obtained after the nature of the study
was explained to every subject.
In alcoholic patients, a history of alcohol con-
sumption was gathered, including duration of 
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alcohol dependence and average daily consump-
tion in the past month. Alcohol consumption
was stopped abruptly at admission. Fixed-dose
detoxification consisted of four doses of 2 mg 
lorazepam, with gradual tapering thereafter, and
trazodone as required for sleep problems. In ad-
dition, oral thiamine supplementation (150 mg/
day) was given routinely to every subject to pre-
vent serious neurological complications.22 The
detoxification ward was a restricted environment
and provided a service for 1–2 weeks. The dura-
tion of hospitalization was decided on the basis
of clinical improvement of alcohol withdrawal
symptoms. All patients received the same meals
supplied by the hospital during their stay.
Biochemical analysis
Venous blood samples were obtained within 24
hours of hospital admission (baseline), and sub-
sequently on day 8 (after 1 week of detoxifica-
tion) and 14 (after 2 weeks of detoxification), for
measurement of serum MDA level and activities
of SOD, CAT and GPX, after an overnight fast.
The blood samples were centrifuged at 1000g for
15 minutes and serum samples were stored at 
−80°C until analysis.
For determination of MDA levels, the pro-
cedure was adapted from that developed by
Jentzsch et al.23 First, 0.5 mL of serum from alco-
holic patients or controls was mixed with 25 μL
butylated hydroxytoluene (88 mg/mL absolute
alcohol) in ethanol. Next, 2.5μL of 0.05 M sulfuric
acid was added and vortexed for 10 seconds, and
left to stand for 10 minutes at room temperature.
Next, 25 μL of 0.2% thiobarbituric acid was added
and vortexed. The reaction mixture was incu-
bated at 100°C for 30 minutes in a water bath.
The tubes were placed on ice to stop the reaction.
After standing at room temperature, thiobarbi-
turic acid reactive substances were extracted with
3 mL n-butanol. The n-butanol phase was cen-
trifuged at 10,000g for 5 minutes. The absorbance
of the n-butanol extract phase was measured at
450–610 nm with a UV/VIS spectrophotometer
(Model V-550; Jasco International Co. Ltd., Tokyo,
Japan).
For determination of SOD activity, Cu/Zn
SOD levels were measured by sandwich ELISA
using commercial kits and standard protocols
(Superoxide Dismutase ELISA kit; ALEXIS Corp.,
Lausen, Switzerland).24 Ten microliters of serum
from alcoholic patients or controls, 50 μL of
anti-SOD–horseradish peroxidase (HRP) conju-
gate, and 100 μL of PBS (pH 7.4) were added 
simultaneously to the wells of a microtitration
plate, which was coated with anti-SOD antibod-
ies (5 μg/mL). The plate was then shaken for 
15 minutes at room temperature. After washing
the wells three times with washing buffer (PBS
with 1% Tween 20, pH 7.4), tetramethylbenzidine
substrate (Sigma, St Louis, MO, USA; 100 μL/
well) was added, and the plate was incubated for
10 minutes at room temperature. The reaction
was stopped by adding 100 μL stop solution (1 M
phosphoric acid) per well. Absorbance values were
read at 450nm using an ELISA reader (Model MRX;
Dynex Technologies Inc., Chantilly, VA, USA). For
standard curve generation, a Cu/Zn-SOD stan-
dard was prepared. Serial fold dilutions (0.08,
0.16, 0.32, 0.63, 1.25, 2.0, and 2.5 ng/mL) of
Cu/Zn-SOD standard yielded a good correlation
of SOD activity (SOD activity = 0.965X + 0.027,
where X = dilution factor of the Cu/Zn-SOD
standard; r2 = 0.9966; data not shown).
The CAT activity in the serum of alcoholic 
patients and control subjects was measured using
a BIOXYTECH Catalase-520 kit (OXIS Research,
Portland, OR, USA) according to the manufac-
turer’s protocol.25 Thirty microliters of serum
from the alcoholic patients or control subjects
was incubated with 500 mL of 10 mM hydrogen
peroxide for 1 minute at 37°C, and the reaction
was stopped by addition of 500 μL sodium azide
solution. Aliquots (20 μL) of the reaction mix-
ture were then incubated with HRP/chromogen
reagent for 10 minutes. Optical densities of
520 nm absorbance were read using an ELISA
reader (Model MCC/340; Labsystems Multiskan,
Farnborough, UK). For standard curve genera-
tion, various amounts of the standard CAT 
were incubated and the second-order poly-
nomial regression was observed (CAT activity, 
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U/mL = 0.00008X2 − 341.73X + 118.54, where
X = absorbance at 520 nm; r2 = 0.9965; data not
shown).
GPX was determined by the Glutathione
Peroxidase Assay Kit (Cayman Chemical Co.,
Ann Arbor, MI, USA) according to the manu-
facturer’s protocol.26 Twenty microliters of the
serum from alcoholic patients or control subjects,
or diluted GPX was added to 100 μL of assay
buffer and 50 μL cosubstrate. Twenty microliters
of cumene hydroperoxide was added to start the
reaction. The plate was incubated in the dark on
an orbital shaker for a few seconds. The absor-
bance at 340 nm was read once every minute using
a microtiter plate reader (MCC/340; Labsystems
Multiskan) to obtain at least five time points.
The actual extinction coefficient for NADPH at
340 nm is 0.00622 μM/cm. One unit of activity
is equal to conversion of 1 nmol NADPH to
NADP+ per minute at 25°C.
Statistical analysis
Data were expressed as mean ± standard devia-
tion. Analysis of covariance (ANCOVA) controlling
potential confounders, especially age, was used
to test the differences of various indexes between
alcoholic and control groups. We used repeated-
measures analysis of variance (ANOVA), with
Bonferroni correction for multiple comparisons,
to determine the differences of various indexes
before and after detoxification in the alcoholic
group. Pearson’s correlation was used to measure
the correlation between numerical variables. 
A value of p < 0.05 was considered statistically
significant. Analyses were carried out using SPSS
version 12.0 (SPSS In., Chicago, IL, USA). Sub-
jects with missing data were excluded from the
analyses.
Results
Clinical characteristics
One hundred and twenty-one patients and 19
healthy control subjects were recruited (Table 1).
The control group (age, 30.4 ± 10.4 years) was
younger than the alcoholic group (age, 42.2 ± 9.0
years). The classical biological markers of chronic
Table 1. Demographic characteristics and biological parameters of alcoholic patients and controls
Controls (n = 19) Alcoholics (n = 121)
Mean ± standard deviation age (yr)* 30.4 ± 10.4 42.2 ± 9.0
Sex
Male 11 113
Female 8 8
Duration of alcohol dependence (yr) – 13.2 ± 8.5 (n = 113)
Mean alcohol consumption (g/d ethanol) – 216.6 ± 107.1 (n = 114)
Cigarettes/d – 23.1 ± 13.1 (n = 110)
Baseline 1-wk detoxification
AST (U/L) 16.8 ± 2.6 130.2 ± 114.7† 53.5 ± 51.8†‡
(n = 109) (n = 90)
ALT (U/L) 14.6 ± 5.3 56.9 ± 66.3† 66.6 ± 74.2†‡
(n = 117) (n = 91)
GGT (U/L) 24.2 ± 7.3 401.1 ± 559.9† 226.8 ± 281.2†‡
(n = 117) (n = 91)
Total bilirubin (mg/dL) 0.6 ± 0.2 1.1 ± 0.9† 0.6 ± 0.5‡
(n = 108) (n = 91)
*Student’s t test, p < 0.05 between control subjects and alcoholics; †significantly different from control group: p < 0.05, analysis of co-
variance between case and control group with age as a covariate; ‡paired t test, p < 0.05 between baseline and 1-week detoxification.
AST = aspartate aminotransferase; ALT = alanine aminotransferase; GGT = g-glutamyltransferase.
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alcoholism, γ-glutamyltransferase (GGT), aspartate
aminotransferase (AST), alanine aminotransferase
(ALT), and total bilirubin were significantly higher
in alcoholic patients than in healthy controls. All
these markers decreased significantly after 1 week
of detoxification.
Twenty-two and 60 patients, respectively, with-
drew from the study during the first and second
week of detoxification. We used ANOVA to com-
pare clinical and biological variables between pa-
tients completing the 2-week study (n = 39), and
those who withdrew during the first (n = 22) and
second (n = 60) week. There were no differences
in mean age (F = 0.14, df = 2, 118, p = 0.87), dura-
tion of alcohol dependence (F = 0.75, df = 2, 110,
p = 0.48), mean alcohol consumption (F = 0.40,
df = 2, 114, p = 0.67), MDA (F = 3.0, df = 2, 118,
p = 0.053), SOD (F = 0.72, df = 2, 118, p = 0.49),
CAT (F = 0.14, df = 2, 118, p = 0.87), and GPX 
(F = 1.19, df = 2, 118, p = 0.31) at baseline among
alcoholic patients who completed the 2-week
study and those who dropped out. In total, 99
patients completed 1 week of detoxification and
39 completed 2 weeks. The low retention rate
(81.2% and 32.8% for weeks 1 and 2, respec-
tively) may be explained in part by intolerance to
the restricted detoxification ward by some patients,
especially those with antisocial behavior—a fre-
quent feature in alcoholic patients. Meanwhile,
since alcohol withdrawal symptoms generally
subside within 1 week, patients who experienced
clinical improvement usually requested to be dis-
charged after 1 week. Besides, there were still a
few patients who refused to undergo withdrawal
of the third blood sample, although they stayed
for 2 weeks. Therefore, only one third of recruited
patients completed the 2-week study.
Expression of oxidative stress markers
There were no differences in baseline oxidative
stress markers between patients completing the
study (n = 39) and those withdrawing during the
first or second week (n = 82). Similarly, no dif-
ferences were found in 1-week oxidative stress
markers between those completing the study
(n = 39) and those withdrawing during the second
week (n = 60). Table 2 displays the results of vari-
ous oxidative stress markers in control and alco-
holic subjects at different time points. As a result
of significant differences in age, we first used age
as a covariate in the comparison of oxidative pa-
rameters between controls and alcoholic subjects
who completed 2 weeks detoxification (n = 39).
Baseline serum MDA levels in the alcoholic group
were significantly higher than in the control group,
started to decrease after 1 week of detoxification,
and normalized at the end of 2 weeks. SOD and
GPX activities in alcoholics were maintained at 
a significantly lower level than those in the con-
trols, and showed no restoration throughout the
2 weeks. CAT activity of alcoholics was not signif-
icantly higher than that of controls at baseline,
Table 2. Expression of oxidative stress markers between control and alcoholic groups
Control 
Alcoholic patients during detoxification
Mean ± SD Baseline 1 wk 2 wk
(n = 19)
n = 39 n = 82* n = 39 n = 60† n = 39
MDA (μM)‡ 4.0 ± 0.9 10.0 ± 6.4§ 8.8 ± 7.4§ 5.0 ± 2.7§|| 5.3 ± 2.6§ 4.6 ± 2.3||
SOD (ng/mL) 159.6 ± 105.3 29.3 ± 21.7§ 30.0 ± 24.6§ 39.6 ± 29.7§ 30.8±29.2§ 31.8 ± 20.2§
CAT (U/mL)‡ 7.6 ± 4.6 9.2 ± 7.1 9.2 ± 7.7 5.7 ± 6.0 5.9 ± 4.6 4.2 ± 3.6§||
GPX (nmol/min/mL) 205.1 ± 44.7 122.9 ± 57.9§ 109.5 ± 59.2§ 129.9 ± 41.2§ 115.6 ± 47.1§ 104.9 ± 48.3§
*Patients who withdrew from the study during week 1 or 2; †patients who withdrew from the study during week 2; ‡F (2, 256) = 21.0
for MDA, and F (2, 76) = 9.0 for catalase: all p < 0.01, repeated-measures analysis of variance before and after detoxification using 39
patients who completed the study; §significantly different from the control group: p < 0.05, analysis of covariance between case 
and control groups with age as a covariate at baseline, 1-week detoxification, and 2-week detoxification; ||significantly different from
baseline: p < 0.05, with Bonferroni correction for multiple comparisons. SD = standard deviation; MDA = malondialdehyde; SOD =
superoxide dismutase; CAT = catalase; GPX = glutathione peroxidase.
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but it was depressed after 1 week of detoxification,
with an even lower level (44% lower) at the end
of 2 weeks detoxification. Since significant differ-
ences were also noted for AST, ALT, GGT and total
bilirubin between alcoholic and control groups,
we compared the differences in various oxidative
parameters at baseline and after 1 week of detox-
ification, using age and laboratory variables as
covariates. Surprisingly, while the differences re-
mained the same for SOD, CAT and GPX activi-
ties, the significance disappeared for MDA level.
Baseline MDA level was not correlated signif-
icantly with clinical variables in alcoholic patients
(n = 121), including age, smoking, age at start of
alcohol dependence, mean alcohol consumption,
and duration of alcohol dependence. We further
examined the relationship between serum MDA
level and various antioxidant indexes. Table 3
demonstrates the correlation between baseline
oxidative stress markers and liver function vari-
ables. At baseline, serum MDA level was correlated
positively with CAT activity (r = 0.29, p < 0.01), but
not with SOD and GPX activities. In addition,
the magnitude of the decrease in MDA was cor-
related positively with that of CAT activity after 
1 week of detoxification (r = 0.27, p < 0.01), but
not with SOD and GPX.
Fifteen patients were positive for hepatitis B
surface antigen (HBsAg) and 85 were negative.
Data were not available for the remaining 21 
patients. None of the oxidative status markers
showed significant differences between patients
with and without HBsAg.
Discussion
The results of the present study, which were in
accordance with our previous findings,21 indicated
that serum MDA level and activities of SOD and
GPX in alcoholic patients were significantly dif-
ferent from those in healthy controls. In alco-
holics, MDA level was significantly higher than
in the controls and gradually normalized after 
2 weeks of detoxification. Meanwhile, there was
a marked and persistent decrease in SOD and
GPX activities throughout the 2-week withdrawal
period. CAT activity in alcoholics was not higher
than in the controls at baseline, but decreased
markedly thereafter, and was even lower than in
the controls after 2 weeks detoxification. Notably,
after controlling for liver function in the com-
parison between alcoholic and control groups 
at baseline and 1-week detoxification, the differ-
ences disappeared for MDA level, while there
was no change for SOD, CAT and GPX activities.
Although there were positive correlations between
baseline MDA level and baseline CAT activity, and
between magnitude of the decrease in MDA level
and magnitude of the decrease in CAT activity after
the 1-week detoxification, the correlation coeffi-
cients were small (0.29 and 0.27, respectively).
The enhanced lipid peroxidation in alco-
holics was in agreement with previous reports.
By analyzing CSF, Tsai et al observed persistently
higher lipid peroxide levels after alcohol with-
drawal.10 Several studies have consistently found
elevated MDA levels in the peripheral blood of
Table 3. Correlation between oxidative stress markers and liver function tests at baseline among alcoholic
patients (n = 121)
MDA SOD CAT GPX AST ALT GGT
MDA 1
SOD 0.06 1
CAT 0.29* 0.27* 1
GPX 0.05 −0.26* −0.02 1
AST 0.46* 0.22† 0.52* 0.06 1
ALT 0.22† 0.24* 0.46* 0.06 0.67* 1
GGT 0.41* 0.06 0.31* 0.12 0.58* 0.30* 1
*p < 0.01; †p < 0.05. MDA = malondialdehyde; SOD = superoxide dismutase; CAT = catalase; GPX = glutathione peroxidase; AST =
aspartate aminotransferase; ALT = alanine aminotransferase; GGT = g-glutamyltransferase.
patients undergoing alcohol withdrawal.11,12,21,27–29
Likewise, our study demonstrated significant ele-
vation in MDA level in alcoholic patients. The level
decreased gradually after 1 week of abstinence
and appeared comparable to that of the control
subjects after 2 weeks detoxification. Thus, it is
suggested that prompt detoxification in alcohol-
dependent patients leads to restoration of pro-
oxidant stress. However, after controlling for liver
function tests, MDA levels at baseline and after
1-week detoxification did not differ from those
in the controls. It has been reported that serum
MDA concentration increases with the severity 
of liver disease.30 Besides, liver damage and lipid
peroxidation are considered as closely connected
processes.31 This implies that the significant ele-
vation of MDA level in alcoholic patients is asso-
ciated with underlying liver impairment, which
contributes to the difference in MDA expression.
However, this point requires confirmation in fu-
ture studies.
SOD is responsible for reducing superoxide
to hydrogen peroxide, and is the chief cellular
defense against ROS. The effects of chronic alco-
hol exposure on the cellular content or activity of
SOD are controversial, with reports of increases,
no change, or decreases, depending on the model,
diet, amount, and time of alcohol consump-
tion.12,16,32 In our study, compared with controls,
SOD activity in alcoholic patients appeared to be
significantly reduced. This is in agreement with
previous reports.11,12,21,27–29 The significant dif-
ference between the two groups at baseline or
after 1 week of detoxification remained, even
after controlling for liver function values in sta-
tistical analysis. We suggest that the decrease in
SOD activity is a distinct feature of chronic alco-
hol exposure. Additionally, depressed SOD activ-
ity persisted throughout 2 weeks of abstinence,
with negligible fluctuation. Although this obser-
vation differed from some studies that have indi-
cated an increase in SOD activity after alcohol
withdrawal,12,16 it was consistent with that of
Tsai et al, who found a long-lasting reduction in
SOD activity in the CSF of alcoholic patients on
days 9 and 33 after alcohol withdrawal.10 SOD is
critical in the detoxification of superoxide, which
can initiate and propagate free radical oxidation.33
Generation of free radicals by alcohol can be de-
pressed by the addition of SOD.34 Consequently,
superoxide is proposed as the primary source for
other oxyradicals that result from alcohol expo-
sure. SOD is most sensitive to and the primary
defense against ROS damage,33 thus, it is depleted
readily and is incapable of prompt compensa-
tion when encountering heavy oxidative injury.
Therefore, we suggest that chronic alcoholism is
associated with attenuated SOD activity, which is
not balanced in the short term.
CAT normally plays a minor role in alcohol
metabolism. It defends against and warrants the
presence of hydrogen peroxide and related free
radicals. It has been reported that chronic alco-
hol ingestion may cause dose-dependent eleva-
tion of CAT activity in rat plasma.35 In our study,
baseline CAT activity in alcoholics was 21%
higher (not statistically significant) than that in
the controls, but started to decrease significantly
after 1 week, and was 44% lower than in the con-
trols at week 2 of detoxification. A previous study
has shown that the increase in erythrocyte CAT
before abstinence in alcoholics is not significantly
different from controls.16 The reasons for the lack
of differential CAT activities between alcoholic
and control groups remain unclear. CAT might
increase in alcoholics to meet the metabolic need
of chronic alcohol ingestion, and return to defec-
tive levels after 2 weeks of abstinence. Animal
studies have shown that CYP2E1 induction by 
alcohol can initiate lipid peroxidation, and as a
result, lead to excessive oxidative injury.36 Over-
expression of CYP2E1 in cells enhances CAT 
expression, which confers resistance against pro-
oxidants.37 These results lend support to our data
that a positive correlation existed between MDA
level and CAT activity, either at baseline or for the
magnitude of the changes after 1-week detoxifi-
cation. Despite the correlation being only modest
and requiring confirmation, it provides an initial
clinical observation that, for alcoholic patients,
there is a trend towards CAT activity elevation to
counteract, at least in part, lipid peroxidation.
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GPX is another cellular defense for removal of
hydrogen peroxide, and it was found to be signif-
icantly lower in alcoholics than in controls. As
with SOD, the drop in GPX activity was persis-
tent during the 2-week withdrawal period. These
results were inconsistent with those in the litera-
ture. For example, Girre et al described a reduc-
tion in GPX activity in alcoholic patients, but the
activity appeared normalized during abstinence.15
In contrast, some studies have shown that the
higher baseline GPX activity decreased signifi-
cantly after alcohol withdrawal.12,16 Even after we
controlled for the potential impact of liver func-
tion, we still found that GPX activity decreased
significantly in alcoholic patients, either at base-
line or after 1-week detoxification. Chronic alco-
hol exposure depresses GPX activity.38 The Km
value of GPX for hydrogen peroxide is much
lower than that for CAT. Hence, GPX has been
postulated to be sensitive to oxidative stress, and
responsible for degrading low levels of hydrogen
peroxide physiologically, while CAT might func-
tion when cellular levels of hydrogen peroxide
are increased.37 In CYP2E1-expressing cells, which
manifest higher lipid peroxidation, the two en-
zymes appear to compensate for each other in
scavenging hydrogen peroxide, because GPX was
decreased by 30%, while CAT was increased two-
fold.37 These observations support our results that
in subjects with increased levels of MDA, CAT 
activity was elevated, whereas GPX was reduced.
We suggest that, apart from SOD activity, alco-
holic patients have severe and prolonged defi-
ciency in GPX activity that needs longer than 
2 weeks of abstinence to improve. Whether there
are differential abnormalities in SOD and/or GPX
activities at different stages of severity of alcohol
dependence remains to be resolved.
Our study had some limitations. First, the ben-
zodiazepine administered for detoxification might
have affected oxidative stress. Some researchers
have reported that diazepam, but not clonaze-
pam, inhibits in vitro superoxide generation from
human neutrophils,39 which implies that clo-
nazepam reduces oxidative stress. However, there
is a paucity of data on the effects of lorazepam
on oxidative stress in humans. Second, we can-
not completely exclude the effect of adjunctive
treatment with thiamine supplementation and
trazodone. Thiamine exhibits direct antioxidant
capacity, and treatment with it may reverse some
oxidative stress parameters in rats.40,41 Since thi-
amine supplementation is mandatory for alco-
holic patients to prevent neurological sequela, we
cannot avoid its confounding effect on oxidative
stress. In addition, an in vitro study has demon-
strated that trazodone has no effect on oxidative
phosphorylation in mitochondria.42 Our investi-
gations did not reveal significant differences in
various oxidative stress indexes between those
with and without trazodone treatment. Thus, the
effect of trazodone (50 mg) on oxidative stress
seems minimal. Third, selection bias such as a
mismatched control group and loss of follow-up
should also be taken into consideration. Further-
more, the control group was younger (30.4 ± 10.4
years) than the alcoholic group (42.2 ± 9.0 years).
Using ANCOVA to control for the age effect, we
found that the differences of oxidative stress in-
dexes between the control and alcoholic groups
remained significant. We speculate that the pos-
sibility of an age effect on oxidative stress in our
study was limited. Fourth, the dietary habits of
our participants were not monitored. Finally, 
because we followed the abstinent alcoholic pa-
tients for only 2 weeks, whether the defects in
SOD and GPX persisted after prolonged absti-
nence remains to be clarified by a longer follow-
up study.
In conclusion, the serial and simultaneous 
assessment of various oxidative indexes showed
that there was marked oxidative stress in the 
alcoholic patients without severe liver disease, as
demonstrated by enhanced lipid peroxidation
and depressed antioxidative mechanisms. The 
attenuation of raised MDA level and lowering 
of CAT activity appeared as early as after 1-week
detoxification. The persistent low activity of SOD
and GPX, as well as suppressed CAT response, 
indicated that alcoholic patients did not scav-
enge free radicals as readily as controls. Intrigu-
ingly, our data indicated, possibly for the first
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time, that the increased MDA levels may have
been influenced by underlying liver abnormali-
ties. These observations of excessive oxidative
stress might link with multiple morbidity in al-
coholic patients. The impact of sustained absti-
nence in chronic alcoholic patients needs to be
further investigated.
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